The present invention relates to new compounds comprising a siderophore moiety as well as a core structure able to chelate a metal ion. Optionally, the compounds may have additionally a moiety with a functional element including a marker molecule, a bioactive agent, an activity based probe suitable to monitor the aberrant expression or activity of proteins involved in the initiation and progression of bacterial infection, or a compound useful for bacterial inhibition. In a further aspect, the present invention provides a pharmaceutical composition containing said compound, for example, said pharmaceutical composition is an antibiotic. Additionally, the present invention relates to the use of said compounds in diagnostic methods, in particular, imaging methods including SPEC, PET or MRI. In an embodiment of the present invention, the compound is part of a theranostic composition having both, therapeutic as well as diagnostic activities.
本发明涉及一种新化合物,其包含一个苷元分子以及一个能够螯合
金属离子的核心结构。可选地,这些化合物还可以具有一个具有功能元素的分子,包括标记分子、
生物活性剂、适用于监测参与细菌感染的起始和进展的蛋白质的异常表达或活性的基于活性的探针,或用于抑制细菌的化合物。在另一方面,本发明提供了一种含有所述化合物的药物组合物,例如,所述药物组合物是一种抗生素。此外,本发明还涉及所述化合物在诊断方法中的用途,特别是成像方法,包括
SPEC、PET 或 MRI。在本发明的一个实施方案中,所述化合物是同时具有治疗和诊断活性的治疗组合物的一部分。